MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Computerized cognitive training in advanced Parkinson’s disease: preliminary feasibility data of an ongoing randomized controlled trial

P. Olgemöller, E. Kalbe, C. Hennen, M. Barbe, M. Hellmich, AK. Folkerts (Cologne, Germany)

Meeting: 2023 International Congress

Abstract Number: 381

Keywords: Parkinson’s

Category: Parkinson's Disease: Cognitive functions

Objective: To analyse the feasibility and effects on cognitive- and non-cognitive outcomes, and prediction of responsiveness of a computerized cognitive training (CT) in comparison to usual care in people with advanced Parkinson’s disease (PD).

Background: Mild cognitive impairment and dementia are frequent in PD and severely affect patients’ quality of life (QoL). Thus, effective pharmacological and non-pharmacological treatment strategies are needed. One approach is CT (i.e., standardized computerised tasks to improve cognitive functioning [e.g., memory, attention, executive functions]). CT has been shown to be effective in PD patients with no or mild cognitive impairment in Hoehn and Yahr stages I-III and without or only slight motor complications. However, studies examining CT effects in advanced PD patients are lacking.

Method: This ongoing monocentric, randomized controlled, single-blinded, two-armed intervention study (registered in the German Clinical Trials Register, ID: DRKS00028876) assesses the effects of a 5-week digital multi-domain CT “NEUROvitalis digital” (4 times/week for 45 minutes) in advanced PD according to the 5-2-1-criteria [1] (n=70) compared to usual care (n=70). Participants undergo extensive neuropsychological testing pre and post CT and at 3 months follow-up. Primary outcome is global cognition assessed by the Montréal Cognitive Assessment (MoCA). Secondary outcomes include, e.g., specific cognitive functions, depression, and QoL. Feasibility is assessed using a training diary on patients’ motivation and satisfaction and technical data from the CT (e.g., training progress, duration).

Results: After two months of recruitment, n=18 PD patients were included. Until now, we report n=2 screening failures (MoCA ≤21), n=0 dropouts, n=4 patients completed the CT already, and n=6 are currently in training. Regarding feasibility, patients follow the training schedule, show good motivation and satisfaction to participate in the CT, and some report minor technical issues.

Conclusion: The trial will inform whether computerised CT will be feasible in terms of technical handling, implementation in everyday life, and motivation and satisfaction of patients with advanced PD. We further expect the CT to improve global cognition as well as other cognitive and non-cognitive outcomes in the short and long term.

References: [1] Antonini, A. (2018): https://doi.org/10.1080/03007995.2018.1502165

To cite this abstract in AMA style:

P. Olgemöller, E. Kalbe, C. Hennen, M. Barbe, M. Hellmich, AK. Folkerts. Computerized cognitive training in advanced Parkinson’s disease: preliminary feasibility data of an ongoing randomized controlled trial [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/computerized-cognitive-training-in-advanced-parkinsons-disease-preliminary-feasibility-data-of-an-ongoing-randomized-controlled-trial/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/computerized-cognitive-training-in-advanced-parkinsons-disease-preliminary-feasibility-data-of-an-ongoing-randomized-controlled-trial/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley